Existing home sales fell in July to weigh the markets down to a lower open with the Dow losing 24 points to 18,523. Nasdaq eased a fraction to 5,259.
On the upside
Uranium Resources (Nasdaq: URRE) acquired a lithium property in Nevada.
The Food and Drug Administration granted clearance to Amedica (Nasdaq: AMDA) for expanded Valeo II Lateral Lumbar sizes.
Lannett (NYSE: LCI) reported better than expected earnings for the fourth quarter as revenue surged and forecast full year revenue ahead of estimates.
On the downside
Express (NYSE: EXPR) disappointed with lower second quarter earnings and revenue that fell short of expectations and slashed its current quarter guidance.
First quarter earnings and revenue for La-Z-Boy (NYSE: LZB) missed estimates.
Shares of Yirendai (NYSE: YRD) fell for the fifth day.
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE while advancers edged out decliners by nearly 9 to 7 on Nasdaq. The broader S&P 500 slipped 2 points to 2,184. Bitcoin lost $1 to $579.
